Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K-H Pyo
Activation of the Met Kinase Confers Acquired Drug Resistance in FGFR-targeted Lung Cancer Therapy
Oncogenesis
Cancer Research
Molecular Biology
Related publications
Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
MET Targeted Therapy for Lung Cancer: Clinical Development and Future Directions
Lung Cancer: Targets and Therapy
Oncology
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
P1.13-20 MET Protein Expression and Activation During Targeted Therapy in EGFR Mutated Lung Adenocarcinoma
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Anti-Met VHH Pool Overcomes MET-targeted Cancer Therapeutic Resistance
Molecular Cancer Therapeutics
Cancer Research
Oncology
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Cancer Research
Cancer Research
Oncology
Amplification of EGFR Wild-Type Alleles in Non–Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors
Cancer Research
Cancer Research
Oncology
Drug Resistance in Lung Cancer
Lung Cancer: Targets and Therapy
Oncology